• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NYR

NYRADA INC.

5.56% ! 28.5¢
Market Cap $68.08M  !

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NYR 17/09/25 30 5.1K
17/09/25 Last post  Bendunstan Comments Created with Sketch.  30  Views Created with Sketch.  5.1K 
NYR 16/09/25 266 43K
16/09/25 Last post  Bendunstan Comments Created with Sketch.  266  Views Created with Sketch.  43K 
NYR 15/09/25 16 2.1K
Healthcare SECTOR NEWS

Green light for NUZ-001: Neurizon secures significant R&D incentive

NUZ
18 Sep 2025
NEURIZON THERAPEUTICS LIMITED
15/09/25 Last post  Bendunstan Comments Created with Sketch.  16  Views Created with Sketch.  2.1K 
NYR 09/09/25 0 197
09/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  197 
NYR 09/09/25 0 144
09/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  144 
NYR
CHART
2 3 4
31/08/25 202 42K
31/08/25 Last post  Bendunstan Comments Created with Sketch.  202  Views Created with Sketch.  42K 
NYR 25/08/25 1 455
25/08/25 Last post  R-7 Comments Created with Sketch.  1  Views Created with Sketch.  455 
NYR 22/08/25 0 197
22/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  197 

See All Discussions arrow Created with Sketch.

Timeline

Xolatryp Protects Cells through Mitochondrial Stabilisation
16 Sep 09:53
 
Change in substantial holding - M Azzi
11 Sep 13:02
 
Cleansing Statement
09 Sep 16:35
 
Application for quotation of securities - NYR
09 Sep 16:31
 
Cleansing Statement
22 Aug 19:03
 
Application for quotation of securities - NYR
22 Aug 18:56
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
28.5¢
Change
0.015(5.56%)
Mkt cap ! $68.08M
Open High Low Value Volume
27.5¢ 28.5¢ 27.5¢ $82.41K 294.8K

Buyers (Bids)

No. Vol. Price($)
1 6946 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 42831 3
View Market Depth
Last trade - 14.41pm 18/09/2025 (20 minute delay) ?
Last
28.5¢
  Change
0.015 ( 5.56 %)
Open High Low Volume
28.0¢ 28.5¢ 28.0¢ 81382
Last updated 14.56pm 18/09/2025 ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.